132 related articles for article (PubMed ID: 12225433)
1. Role of anti-beta 2 glycoprotein 1 antibodies in ESRD patients with antiphospholipid antibody syndrome.
Vaidya S; Daller J; Gugliuzza K
Clin Transplant; 2002 Oct; 16(5):362-7. PubMed ID: 12225433
[TBL] [Abstract][Full Text] [Related]
2. Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study.
Vaidya S; Sellers R; Kimball P; Shanahan T; Gitomer J; Gugliuzza K; Fish JC
Transplantation; 2000 Apr; 69(7):1348-52. PubMed ID: 10798752
[TBL] [Abstract][Full Text] [Related]
3. Relative risk of post-transplant renal thrombosis in patients with antiphospholipid antibodies.
Vaidya S; Wang CC; Gugliuzza C; Fish JC
Clin Transplant; 1998 Oct; 12(5):439-44. PubMed ID: 9787955
[TBL] [Abstract][Full Text] [Related]
4. IgG2 subclass restriction of anti-beta 2 glycoprotein 1 antibodies in autoimmune patients.
Arvieux J; Roussel B; Ponard D; Colomb MG
Clin Exp Immunol; 1994 Feb; 95(2):310-5. PubMed ID: 8306507
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of beta 2-glycoprotein 1 recognized by antiphospholipid antibodies and its clinical investigation.
Chen S; Yang C; Shen N; Xue F
Chin Med J (Engl); 1999 Jan; 112(1):67-71. PubMed ID: 11593645
[TBL] [Abstract][Full Text] [Related]
6. Detection of anti-recombinant beta 2-glycoprotein 1 and anti-recombinant beta 2-glycoprotein 1 fifth-domain antibodies in sera from patients with systemic lupus erythematosus.
Yang CD; Chen SL; Shen N; Qi M; Xu F
Rheumatol Int; 1998; 18(1):5-10. PubMed ID: 9672992
[TBL] [Abstract][Full Text] [Related]
7. Beta 2-glycoprotein 1 (beta 2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies.
Pierangeli SS; Harris EN; Davis SA; DeLorenzo G
Br J Haematol; 1992 Nov; 82(3):565-70. PubMed ID: 1486036
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of the occurrence of beta-2-glycoprotein I antibodies (anti-beta-2-GPI) and anticardiolipin antibodies (ACA) in the blood of pregnant women].
Fialová L; Mikulíková L; Malbohan I; Benesová O; Zwinger A
Ceska Gynekol; 1999 Jul; 64(4):255-61. PubMed ID: 10568065
[TBL] [Abstract][Full Text] [Related]
9. Ten-yr renal allograft survival of patients with antiphospholipid antibody syndrome.
Vaidya S
Clin Transplant; 2012; 26(6):853-6. PubMed ID: 22507396
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies in children without and in adults with and without thrombophilia.
Siemens HJ; Gutsche S; Brückner S; Bucsky P; Katus HA
Thromb Res; 2000 May; 98(4):241-7. PubMed ID: 10822070
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity and immunochemical properties of anti-beta2-glycoprotein I autoantibodies.
Arvieux J; Regnault V; Hachulla E; Darnige L; Roussel B; Bensa JC
Thromb Haemost; 1998 Sep; 80(3):393-8. PubMed ID: 9759616
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies in COVID-19-associated pneumonia patients in intensive care unit.
Karahan S; Erol K; Yuksel RC; Artan C; Celik I
Mod Rheumatol; 2022 Jan; 32(1):163-168. PubMed ID: 33620009
[TBL] [Abstract][Full Text] [Related]
13. Factor VII/VIIa: a new antigen in the anti-phospholipid antibody syndrome.
Bidot CJ; Jy W; Horstman LL; Huisheng H; Jimenez JJ; Yaniz M; Ahn YS
Br J Haematol; 2003 Feb; 120(4):618-26. PubMed ID: 12588348
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of prothrombin activation by antiphospholipid antibodies and beta 2-glycoprotein 1.
Goldsmith GH; Pierangeli SS; Branch DW; Gharavi AE; Harris EN
Br J Haematol; 1994 Jul; 87(3):548-54. PubMed ID: 7993795
[TBL] [Abstract][Full Text] [Related]
15. Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human beta 2 glycoprotein 1 or anticardiolipin antibodies alone.
Pierangeli SS; Harris EN
Clin Exp Immunol; 1993 Aug; 93(2):269-72. PubMed ID: 8348755
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C.
Leroy V; Arvieux J; Jacob MC; Maynard-Muet M; Baud M; Zarski JP
Br J Haematol; 1998 Jun; 101(3):468-74. PubMed ID: 9633888
[TBL] [Abstract][Full Text] [Related]
18. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
19. Cellular immunity to beta 2-glycoprotein-1 in patients with the antiphospholipid syndrome.
Visvanathan S; McNeil HP
J Immunol; 1999 Jun; 162(11):6919-25. PubMed ID: 10352314
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibody syndrome and renal disease.
Joseph RE; Radhakrishnan J; Appel GB
Curr Opin Nephrol Hypertens; 2001 Mar; 10(2):175-81. PubMed ID: 11224691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
